护士健康研究中女性肥胖与系统性红斑狼疮风险的前瞻性队列分析
该前瞻性队列纳入护士健康研究(NHS与NHSII)238,130名女性,评估肥胖与系统性红斑狼疮(SLE)发病风险的关系。NHSII中肥胖与SLE风险显著相关(HR=1.85),但NHS中无显著关联(HR=1.11),两队列荟萃分析未达统计学显著(HR=1.46)。
要点
- 在较近期的NHSII队列中,肥胖女性较正常BMI女性SLE风险增加85%(HR=1.85)。
- 在较早的NHS队列中,肥胖与SLE风险无显著关联(HR=1.11)。
- 两队列荟萃分析显示肥胖与SLE风险关联不显著(HR=1.46)。
核心结论
- 在较近期的NHSII队列中,肥胖与SLE风险显著增加相关,而较早的NHS队列中未观察到关联,肥胖的时代趋势可能解释两出生队列间的差异。
研究设计与样本
- 前瞻性队列研究,纳入NHS(1976-2012)和NHSII(1989-2013)共238,130名女性。
- SLE病例经美国风湿病学会1997标准确认并通过病历复核验证。
- 采用Cox比例风险模型估计累积平均BMI分类与SLE风险的HR(95%CI),并校正时变混杂因素。
- 两队列分别建模后进行荟萃分析,并开展敏感性分析(简单时变BMI、4年滞后、18岁时BMI及体重变化)。
主要发现
- 随访5,602,653人年期间,NHS发生153例SLE,NHSII发生115例SLE。
- 基线时NHS肥胖比例为8.4%,NHSII为11.8%;入组平均年龄NHS为42.5(SD 7.2)岁,NHSII为34.4(SD 4.7)岁。
- 与正常BMI相比,累积平均肥胖在NHSII中与SLE风险显著相关[HR=1.85(1.17-2.91)],在NHS中无显著关联[HR=1.11(0.65-1.87)]。
- 两队列荟萃分析中,肥胖与SLE风险无显著关联[HR=1.46(0.88-2.40)]。
- NHSII中18岁至入组期间体重增加4.54 kg轻微增加SLE风险[HR=1.09(1.02-1.18)];二次分析中NHS肥胖的HR为1.67(0.81-3.45)。
关键数值与推荐
- SLE确诊采用美国风湿病学会1997标准。
- BMI分类:正常18.5至<25(参照)、超重25至<30、肥胖≥30 kg/m2。
- 主要分析采用累积平均BMI,敏感性分析包括简单时变BMI和4年滞后暴露窗口。
临床怎么用
- 在近期出生队列中,肥胖女性SLE风险升高,提示体重管理可能对SLE预防有潜在意义。
- 不同出生队列间关联存在差异,临床评估SLE风险时应考虑年龄与肥胖时代趋势。
局限性
- 两队列结果不一致且荟萃分析未达统计学显著,关联证据不稳健。
- 观察性设计不能排除残余混杂,尽管采用了滞后分析应对反向因果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is increasingly prevalent and related to increased risk of several autoimmune diseases, likely via generation of inflammatory adipokines. Prior studies have not evaluated obesity in relation to systemic lupus erythematosus (SLE) risk. We prospectively evaluated whether obesity was associated with increased SLE risk among women in the U.S. Nurses' Health Study cohorts. METHODS: We conducted a prospective cohort study among 238,130 women in the Nurses' Health Studies (NHS, 1976-2012; NHSII, 1989-2013). Incident SLE was confirmed by American College of Rheumatology 1997 criteria and validated through medical record review. Body mass index (BMI, kg/m2) was calculated at baseline and on biennial questionnaires. Cox proportional hazards models estimated HRs (95% CIs) for SLE by cumulative average BMI category {18.5 to <25 [normal (reference)], 25 to <30 (overweight), ≥30 (obese)}, adjusting for potential time-varying confounders. Models were performed separately in each cohort; results were meta-analyzed. Sensitivity analyses used simple time-varying BMI, a 4-year lag between exposure and SLE risk window to address potential reverse causation, and evaluated BMI at age 18 and weight change since age 18. A secondary analysis started follow-up in both cohorts at similar calendar years when the prevalence of obesity in the U.S. increased most dramatically [1988 (NHS)/1989 (NHSII)]. RESULTS: We identified 153 NHS incident SLE cases and 115 incident NHSII cases during 5,602,653 person-years of follow-up. At baseline, 8.4% of women in NHS and 11.8% in NHSII were obese. Mean age at enrollment was 42.5 (SD 7.2) years in NHS and 34.4 (SD 4.7) years in NHSII. Cumulative average obesity was significantly associated with SLE risk in NHSII [HR = 1.85 (1.17-2.91)], but not in NHS [HR = 1.11 (0.65-1.87)] compared to normal BMI. In the meta-analysis of both cohorts, obesity was not significantly associated with increased risk of SLE [HR = 1.46 (0.88-2.40)]. Simple time-varying BMI and lagging the exposure window by 4 years produced similar findings to the primary analysis. In NHSII, a 4.54 kg gain between age 18 and enrollment slightly increased SLE risk [HR = 1.09 (1.02-1.18)]. In the secondary analysis starting follow-up of both cohorts at similar calendar years, the point estimate for obesity in NHS was higher than the primary analysis [HR = 1.67 (0.81-3.45)]. CONCLUSION: We observed an 85% significantly increased risk of SLE among obese compared to normal BMI women in the more recent NHSII cohort, but no association was observed in the earlier NHS cohort. Secular trends in obesity may account for the differences between the two birth cohorts.
引用
- Tedeschi SK, Barbhaiya M, Malspeis S, et al. Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies. Semin Arthritis Rheum. 2017. PMID: 28688713. doi:10.1016/j.semarthrit.2017.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。